The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization
Sign Up to like & getrecommendations! Published in 2020 at "Gut and Liver"
DOI: 10.5009/gnl19197
Abstract: Background/Aims The Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 and modified RECIST (mRECIST) criteria have been used to assess treatment responses for hepatocellular carcinoma (HCC) patients. We investigated which criteria provides better survival predictions… read more here.
Keywords: tumors recist; solid tumors; response; criteria solid ... See more keywords